Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

590 Articles

More CPI Inflation More Problems: Analysts Upgrade or Downgrade Block, CSX, Merck and More

Chris Lange | Sep 14, 2022 at 11:30 AM EDT

8 Safe ‘Strong Buy’ Health Care Dividend Stocks to Buy as Summer Bear Market Rally Ends

The bear market rally that started in June is over and it is clearly a time to move to safer…

Lee Jackson | Jun 6, 2022 at 8:45 AM EDT

Monday’s Top Analyst Upgrades and Downgrades: Bristol-Myers, Cheniere Energy, Chewy, Costco, CrowdStrike, Spotify and More

Monday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Cheniere Energy, Chewy, Costco Wholesale, CrowdStrike, Exact Sciences, Lululemon Athletica, New…

Paul Ausick | Apr 27, 2022 at 12:03 PM EDT

Earnings Previews: AbbVie, AstraZeneca, Bristol-Meyers Squibb

Here are previews of three pharmaceutical giants set to report earnings before markets open on Friday.

Chris Lange | Apr 6, 2022 at 3:25 PM EDT

New Era of the Activist Investor, and More Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, JetBlue and More

Wednesday’s additional top analyst upgrades and downgrades included AbbVie, Bristol-Myers, JetBlue, and more.

Lee Jackson | Mar 18, 2022 at 7:26 AM EDT

Fund Managers Pile Into Big Dividend Health Care Stocks: 8 ‘Strong Buy’ Winners

A recent survey of global fund managers found that many have turned to health care for some stability in these…

Lee Jackson | Dec 20, 2021 at 9:00 AM EST

Monday’s Top Analyst Upgrades and Downgrades: AT&T, Deere, Eli Lilly, 3M, Starbucks, Roblox, Tapestry, Tesla and More

Monday's top analyst upgrades and downgrades included Adobe, Arista Networks, AT&T, Bristol-Myers Squibb, Canopy Growth, Deere, Eli Lilly, Invesco, Medtronic,…

Lee Jackson | Dec 10, 2021 at 8:40 AM EST

Friday’s Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Cloudflare, Diageo, Eli Lilly, Rio Tinto, Southwest Airlines and More

Friday’s top analyst upgrades and downgrades included Altice USA, AppLovin, Biogen, Bristol-Myers Squibb, Broadcom, Ciena, Cloudflare, Denison Mines, Diageo, Eli…

Lee Jackson | Nov 24, 2021 at 7:25 AM EST

Top Strategist Says Health Care Could Rule in 2022: 5 Dividend Winners

With the potential for far lower returns in the coming year, total return becomes a key ingredient for investment success.…

Lee Jackson | Nov 18, 2021 at 7:35 AM EST

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

Health care is poised to benefit from a shift toward more defensive sectors. These five stocks have strong balance sheets,…

Chris Lange | Nov 1, 2021 at 11:45 AM EDT

Monday Afternoon Analyst Upgrades and Downgrades: Bristol-Myers, Intel, Merck, Newell, Snap and More

Monday afternoon's analyst upgrades and downgrades included Bristol-Myers Squibb, Intel, Merck, Newell Brands, Snap, Spotify Technology and Tilray.

Lee Jackson | Nov 1, 2021 at 7:35 AM EDT

5 Big Dividend Biotech and Pharmaceutical Stocks Have Strong Upside Potential

In this massively overbought market, health care stocks could benefit from a shift toward more defensive sectors. These five offer…

Lee Jackson | Aug 4, 2021 at 7:35 AM EDT

4 Big Pharma Dividend Stocks to Buy as Yields Near 2021 Lows

These four big pharmaceutical stocks are rated Buy by top Wall Street firms and look like very good ideas for…

Lee Jackson | Jul 30, 2021 at 7:49 AM EDT

6 Goldman Sachs Top Stock Picks Also Pay Big-Time Dependable Dividends

These six top Goldman Sachs stock picks all pay healthy dividends and offer great total return potential and less potential…

Lee Jackson | Jul 27, 2021 at 8:50 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, American Airlines, Chipotle, JD.com, Pfizer, Starbucks and More

Tuesday's top analyst upgrades and downgrades included AbbVie, Alibaba, American Airlines, AT&T, Chipotle Mexican Grill, JD.com, Kimberly-Clark, Pfizer, Starbucks and…

1 … 7 8 9 10 11 … 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

More CPI Inflation More Problems: Analysts Upgrade or Downgrade Block, CSX, Merck and More

8 Safe ‘Strong Buy’ Health Care Dividend Stocks to Buy as Summer Bear Market Rally Ends

Monday’s Top Analyst Upgrades and Downgrades: Bristol-Myers, Cheniere Energy, Chewy, Costco, CrowdStrike, Spotify and More

Earnings Previews: AbbVie, AstraZeneca, Bristol-Meyers Squibb

New Era of the Activist Investor, and More Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, JetBlue and More

Fund Managers Pile Into Big Dividend Health Care Stocks: 8 ‘Strong Buy’ Winners

Monday’s Top Analyst Upgrades and Downgrades: AT&T, Deere, Eli Lilly, 3M, Starbucks, Roblox, Tapestry, Tesla and More

Friday’s Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Cloudflare, Diageo, Eli Lilly, Rio Tinto, Southwest Airlines and More

Top Strategist Says Health Care Could Rule in 2022: 5 Dividend Winners

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

Monday Afternoon Analyst Upgrades and Downgrades: Bristol-Myers, Intel, Merck, Newell, Snap and More

5 Big Dividend Biotech and Pharmaceutical Stocks Have Strong Upside Potential

4 Big Pharma Dividend Stocks to Buy as Yields Near 2021 Lows

6 Goldman Sachs Top Stock Picks Also Pay Big-Time Dependable Dividends

Tuesday’s Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, American Airlines, Chipotle, JD.com, Pfizer, Starbucks and More

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Monthly Gold Income of $4.43 Appeals to Retirees; Volatility Decline Threatens The Flow

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

More CPI Inflation More Problems: Analysts Upgrade or Downgrade Block, CSX, Merck and More

8 Safe ‘Strong Buy’ Health Care Dividend Stocks to Buy as Summer Bear Market Rally Ends

Monday’s Top Analyst Upgrades and Downgrades: Bristol-Myers, Cheniere Energy, Chewy, Costco, CrowdStrike, Spotify and More

Earnings Previews: AbbVie, AstraZeneca, Bristol-Meyers Squibb

New Era of the Activist Investor, and More Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, JetBlue and More

Fund Managers Pile Into Big Dividend Health Care Stocks: 8 ‘Strong Buy’ Winners

Monday’s Top Analyst Upgrades and Downgrades: AT&T, Deere, Eli Lilly, 3M, Starbucks, Roblox, Tapestry, Tesla and More

Friday’s Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Cloudflare, Diageo, Eli Lilly, Rio Tinto, Southwest Airlines and More

Top Strategist Says Health Care Could Rule in 2022: 5 Dividend Winners

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

Monday Afternoon Analyst Upgrades and Downgrades: Bristol-Myers, Intel, Merck, Newell, Snap and More

5 Big Dividend Biotech and Pharmaceutical Stocks Have Strong Upside Potential

4 Big Pharma Dividend Stocks to Buy as Yields Near 2021 Lows

6 Goldman Sachs Top Stock Picks Also Pay Big-Time Dependable Dividends

Tuesday’s Top Analyst Upgrades and Downgrades: AbbVie, Alibaba, American Airlines, Chipotle, JD.com, Pfizer, Starbucks and More

FIDI’s 4.1% Yield Holds Firm as Dollar Weakness Boosts International Dividends

Why BDC Income Investors Are Facing Smaller Quarterly Checks in 2026

Monthly Gold Income of $4.43 Appeals to Retirees; Volatility Decline Threatens The Flow

Featured Reads

A $1.8 Million 401(k) and Social Security Coming Up? Drain It Before 70 to Dodge the IRMAA Cliff

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)